<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03344107</url>
  </required_header>
  <id_info>
    <org_study_id>AOUCSSTURAB003</org_study_id>
    <nct_id>NCT03344107</nct_id>
  </id_info>
  <brief_title>Stent-related Symptoms Comparison: Polaris Loop vs Vortek Double-J Stents</brief_title>
  <official_title>Comparison Between Symptoms Related to Polaris Loop Stent Versus Vortek Double J Stent After Uncomplicated Flexible Ureterorenoscopy for Renal Stones</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliera Città della Salute e della Scienza di Torino</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliera Città della Salute e della Scienza di Torino</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective randomized controlled single-blind parallel-group trial in order to compare&#xD;
      symptoms related to loop-tail (Polaris Loop) stents versus conventional double J (Vortek)&#xD;
      stents after uncomplicated flexible URS.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients undergoing RIRS for a single renal stone &lt; 2 cm are asked to participate in a&#xD;
      prospective randomized controlled single-blind parallel-group study. Ureteral stent is always&#xD;
      placed after flexible URS. Patients are prospectively randomized into two groups with a 1:1&#xD;
      allocation: group LT receive loop-tail stents (Polaris ™ Loop - Boston Scientific, Natick,&#xD;
      USA), while group DJ receive conventional double J stents (Vortek ® - Coloplast, Humlebaek,&#xD;
      DK). Stent removal is planned 4 weeks after the procedure.&#xD;
&#xD;
      Participants are asked to fill in the Italian validated version of the Ureteral Stent&#xD;
      Symptoms Questionnaire (USSQ) 2 days and 4 weeks after surgery. The USSQ is further submitted&#xD;
      4 weeks after stent removal (8 weeks after surgery) and these results are used as baseline&#xD;
      evaluation, on the assumption that SRS persist for a few days after removal.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 10, 2018</start_date>
  <completion_date type="Actual">April 17, 2020</completion_date>
  <primary_completion_date type="Actual">February 13, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>USSQ Urinary symptoms scores</measure>
    <time_frame>4 weeks</time_frame>
    <description>Evaluation of significant differences in Urinary symptoms score between the two groups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>USSQ domains scores</measure>
    <time_frame>4 weeks</time_frame>
    <description>Evaluation of significant differences in USSQ domains' scores between the two groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>USSQ domains scores</measure>
    <time_frame>2 days</time_frame>
    <description>Evaluation of significant differences in USSQ domains' scores between the two groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>USSQ domains' scores adjusted for baseline</measure>
    <time_frame>8 weeks</time_frame>
    <description>Evaluation of significant differences in USSQ domains' scores adjusted for baseline between the two groups</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">68</enrollment>
  <condition>Symptoms and Signs</condition>
  <condition>Pain</condition>
  <condition>Renal Calculi</condition>
  <arm_group>
    <arm_group_label>Vortek double-J stent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Vortek double-J stent after RIRS.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Polaris Loop stent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Polaris Loop ureteral stent after RIRS.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>USSQ questionnaire administration after RIRS.</intervention_name>
    <description>USSQ symptoms questionnaire administration after RIRS</description>
    <arm_group_label>Polaris Loop stent</arm_group_label>
    <arm_group_label>Vortek double-J stent</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients undergoing flexible ureteroscopy and laser lithotripsy for kidney stones &lt; 2&#xD;
             cm&#xD;
&#xD;
          -  given informed consent&#xD;
&#xD;
          -  WHO PS 0-2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  significant residual fragments at the end of the procedure&#xD;
&#xD;
          -  intraoperative complications (i.e. ureteral damage or ureteral stricture)&#xD;
&#xD;
          -  urinary tract infections&#xD;
&#xD;
          -  anatomic abnormalities&#xD;
&#xD;
          -  chronic diseases or medications potentially influencing pain perception and urinary&#xD;
             symptoms (i.e. alpha blockers and antimuscarinics)&#xD;
&#xD;
          -  preoperative ureteral stenting.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrea Bosio, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AOU Città della Salute e della Scienza, Torino</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>AOU Città della Salute e della Scienza</name>
      <address>
        <city>Torino</city>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 11, 2017</study_first_submitted>
  <study_first_submitted_qc>November 11, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2017</study_first_posted>
  <last_update_submitted>November 29, 2020</last_update_submitted>
  <last_update_submitted_qc>November 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliera Città della Salute e della Scienza di Torino</investigator_affiliation>
    <investigator_full_name>Andrea Bosio</investigator_full_name>
    <investigator_title>MD Urologist, PhD</investigator_title>
  </responsible_party>
  <keyword>Symptoms and Signs</keyword>
  <keyword>Pain</keyword>
  <keyword>Renal Calculi</keyword>
  <keyword>Ureteral Stent</keyword>
  <keyword>Ureteroscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Calculi</mesh_term>
    <mesh_term>Nephrolithiasis</mesh_term>
    <mesh_term>Calculi</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

